Skip to content

Effect of the NBS on the treatment of nosocomial infections

Investigating the effect of the Nutrition Bio-Shield (NBS) herbal supplement on the treatment of patients with nosocomial multi-drug resistant bloodstream infections admitted to emergency Intensive care unit.

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230116057135N3
Enrollment
94
Registered
2023-06-10
Start date
2023-06-22
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hospital-acquired bloodstream infections. Bacterial infection, unspecified

Interventions

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Confirmation of the occurrence of sepsis in patients with the initial assessment of the patient's clinical symptoms and laboratory parameters Patients over 18 years old Primary diagnosis of sepsis (have at least two of the following four symptoms: hypothermia or hyperthermia, tachycardia, tachypnea, and leukocytosis or leukopenia) by an infectious specialist or a positive MDR culture

Exclusion criteria

Exclusion criteria: History of consuming corticosteroids and immunosuppressive drugs Pregnant and lactating mothers

Design outcomes

Primary

MeasureTime frame
Measurement of inflammatory factors. Timepoint: Measurement at the beginning of the study (before the start of the intervention) and 14 days after the start of NBS powder consumption. Method of measurement: Gold standard methods (ESR measurement by Westergren method, CRP measurement by Electrochemical Immunoassay method).;Measurement of white blood cells. Timepoint: Measurement at the beginning of the study (before the start of the intervention) and 14 days after the start of NBS powder consumption. Method of measurement: Cell Counter.

Secondary

MeasureTime frame
Mortality Rate. Timepoint: After completing the intervention. Method of measurement: Checking the patient's clinical symptoms.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehrdad Mosadegh

Tehran University of Medical Sciences

m-mosadegh@razi.tums.ac.ir+98 935 563 3390

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026